Clinical trial
The Influence of Treatment Format on Effectiveness of and Dropout From Schema Therapy for Borderline Personality Disorder: Individual vs. Combined Individual Group Schema Therapy
NCT05986552 is registered in ClinicalTrials.gov with University of Amsterdam as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Influence of Treatment Format on Effectiveness of and Dropout From Schema Therapy for Borderline Personality Disorder: Individual vs. Combined Individual Group Schema Therapy
- Lead sponsor
- University of Amsterdam
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- November 10, 2023
- Completion date
- August 30, 2030
- Enrollment
- 132 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.